The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
| 2 | H03 | Thyroid therapy | |
| 3 | H03B | Antithyroid preparations | |
| 4 | H03BC | Perchlorates |
| Code | Title | |
|---|---|---|
| H03BC01 | Potassium perchlorate |
| Active Ingredient | Description | |
|---|---|---|
| Potassium perchlorate |
|
|
| Sodium perchlorate |
Perchlorate competitively inhibits the thyroid’s iodine uptake mechanism, iodination and affects iodisation by flushing the thyroid of iodide that is accumulating but has not yet been incorporated into a thyroglobulin molecule. Re-utilisation of iodide released outside the thyroid during deiodination of thyroid hormone is also inhibited. The antithyroid effect is based on the occurrence of iodine depletion. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| IRENAT Oral drops | Base de données publique des médicaments (FR) | MPI, EU: SmPC |
